Articles by author - Alexandra Žourková

Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.

Barteček R, Juřica J, Zrůstová J, Kašpárek T, Pindurová E, Žourková A.

Journal Article 2012; 33(2): 236-244 PubMed PMID: 22592207  Keywords:  Adolescent, Adult, Aged, Alleles, Antipsychotic Agents:adverse effects, Cytochrome P-450 CYP2D6:genetics, Female, Genotype, Humans, Male, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales:statistics & numerical data, Psychotic Disorders:d.    Citation

OBJECTIVE: The objective of this prospective, naturalistic study, conducted in first-episode psychosis patients from a Central-European po.....

Read abstract  Full text PDF

Dexamethasone suppression test in first-episode schizophrenia.

Cesková E, Kaspárek T, Zourková A, Prikryl R.

Clinical Trial 2006; 27(4): 433-437 PubMed PMID: 16892008  Keywords:  Adult, Anxiety:physiopathology, Depression:physiopathology, Dexamethasone, Feedback, Physiological:drug effects, Follow-Up Studies, Glucocorticoids, Humans, Hydrocortisone:blood, Hypothalamo-Hypophyseal System:physiology, Immunosuppression, Male, Pituitar.    Citation

OBJECTIVES: Higher rates of dexamethasone test (DST) nonsuppression in schizophrenia have been attributed to depressive symptoms, suicidal.....

Read abstract  Full text PDF